Stockscreener 앱 받기
20.17
2.89%
-0.60
Arrivent Biopharma Inc 주식(AVBP)의 최신 뉴스
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by California State Teachers Retirement System - Defense World
Where are the Opportunities in (AVBP) - news.stocktradersdaily.com
Bank of America Corp DE Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Millennium Management LLC Reduces Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Comparing Immutep (NASDAQ:IMMP) and ArriVent BioPharma (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of “Buy” by Analysts - Defense World
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MyChesCo
BNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,327 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Promising Outlook for ArriVent BioPharma: Buy Rating Justified by Upcoming EGFR PACC Mutant NSCLC Program Updates - TipRanks
Deutsche Bank AG Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.5% – Here’s What Happened - Defense World
Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World
Wall Street Zen Downgrades ArriVent BioPharma (NASDAQ:AVBP) to Strong Sell - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jones Trading - Defense World
JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with - GuruFocus
ArriVent BioPharma (AVBP) Coverage Initiated with 'Buy' Rating | - GuruFocus
JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with Optimistic Outlook | AVBP Stock News - GuruFocus
Northern Trust Corp Purchases 10,498 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN
Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo
When the Price of (AVBP) Talks, People Listen - news.stocktradersdaily.com
Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $40.00 - Defense World
Price T Rowe Associates Inc. MD Has $293,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
B. Riley Lifts Earnings Estimates for ArriVent BioPharma - Defense World
Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors - MyChesCo
ArriVent BioPharma (AVBP) Receives Price Target Increase by HC W - GuruFocus
Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AV - GuruFocus
ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AVBP Stock News - GuruFocus
Voya Investment Management LLC Acquires Shares of 8,373 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Tower Research Capital LLC TRC Has $43,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView
ArriVent Biopharma (AVBP) Projects Financial Stability Through 2 - GuruFocus
ArriVent Biopharma (AVBP) Projects Financial Stability Through 2026 | AVBP Stock News - GuruFocus
ArriVent (AVBP) Advances Oncology Pipeline with Key Milestones Ahead | AVBP Stock News - GuruFocus
ArriVent BioPharma Reports First Quarter 2025 Financial Results - The Manila Times
ArriVent BioPharma (AVBP) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (AVBP) - news.stocktradersdaily.com
Arrivent Biopharma Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World
Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World
Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma Appoints Dr. Merdad Parsey to Board of Directors - MyChesCo
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - The Manila Times
Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MyChesCo
ArriVent BioPharma appoints new board member By Investing.com - Investing.com South Africa
ArriVent BioPharma appoints new board member - Investing.com Australia
ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - citybiz
ArriVent BioPharma (AVBP) Strengthens Leadership with New Board - GuruFocus
ArriVent BioPharma (AVBP) Strengthens Leadership with New Board Appointment | AVBP Stock News - GuruFocus
1.08%
2.14%
자본화:
|
볼륨(24시간):